comprehensive -WSS

comprehensive

author：fashion 2025-09-29 21:26:13 - browse：243

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： The drug industry has found itself all alone in Washington

WSS

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Novo Nordisk obesity pill bests Wegovy in early trial

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Male and female sex labels in research insufficient, scientists say

President Biden's budget: Here's what you might have missed

UnitedHealth quietly bought dozens of outpatient centers

hotspot

comprehensive

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Jerome Adams on the need for new antivirals for Covid

Headspace, Meta partner to launch VR meditation app for Quest

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: CAR

Jerome Adams on the need for new antivirals for Covid

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

leisure time

With psoriasis trial ahead, Alumis raises $259 million

Change Healthcare cyberattack prompts Medicare loan program

UnitedHealth quietly bought dozens of outpatient centers

Why depression after traumatic brain injury is distinct

Amid AI frenzy, a top HHS official's quest to create safeguards

John Green on his newest strategy for fighting tuberculosis

knowledge

leisure time

Wikipedia

hotspot